Drug therapy for Alzheimer's disease
- PMID: 15111454
- PMCID: PMC395793
- DOI: 10.1503/cmaj.1031685
Drug therapy for Alzheimer's disease
Comment on
-
Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease: a meta-analysis.CMAJ. 2003 Sep 16;169(6):557-64. CMAJ. 2003. PMID: 12975222 Free PMC article. Review.
Similar articles
-
Meta-analysis of tacrine for Alzheimer disease: the influence of industry sponsors.JAMA. 1999 Jun 23-30;281(24):2287-8. doi: 10.1001/jama.281.24.2287. JAMA. 1999. PMID: 10386551 No abstract available.
-
[Cholinesterase inhibitors and Alzheimer's disease: meta-analysis of the verification of effectiveness, origin and bias of results in published studies].Dtsch Med Wochenschr. 2007 Jun 1;132(22):1207-13. doi: 10.1055/s-2007-979399. Dtsch Med Wochenschr. 2007. PMID: 17520505 German.
-
Cholinesterase inhibitors for Alzheimer disease.JAMA. 2003 May 14;289(18):2360; author reply 2360-1. doi: 10.1001/jama.289.18.2360-a. JAMA. 2003. PMID: 12746355 No abstract available.
-
[Drug therapy for Alzheimer's disease].Brain Nerve. 2010 Jul;62(7):777-85. Brain Nerve. 2010. PMID: 20675882 Review. Japanese.
-
Cholinesterase inhibitors for Alzheimer's disease.Hosp Pract (1995). 1998 Nov 15;33(11):131-6. doi: 10.3810/hp.1998.11.117. Hosp Pract (1995). 1998. PMID: 9826962 Review.
References
-
- Homma A, Takeda M, Imai Y, Udaka F, Hasegawa K, Kameyama M, et al. Clinical efficacy and safety of donepezil on cognitive and global function in patients with Alzheimer's disease. A 24-week, multicenter, double-blind, placebo-controlled study in Japan. E2020 Study Group. Dement Geriatr Cogn Disord 2000;11: 299-313. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical